Sebi's proposed tweaks likely to lead to big churn in F&O stocks

The market regulator’s newly proposed selection criteria for the over Rs 400-trillion-a-day futures and options (F&O) market could pave the way for the entry of popular stocks such as Life......

Pharma cos in bonus issue mode

Buoyed by a strong financial performance, a handful of pharmaceutical companies are coming out with bonus issues and marketmen expect some more to follow suit. FDC has joined the bandwagon by......

Drug firms setting up crack R&D teams

Pharmaceutical companies are furiously trying to set up 'research advisory boards' and are scouring the globe for former research heads of pharmaceutical MNCs, faculty heads of research institutes......

Lower input costs may aid pharma firms' Q2 margins

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and......